Go Pro

Lisata Therapeutics (LSTA) Institutional Ownership

Lisata Therapeutics logo
$1.74 -0.02 (-1.14%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$1.75 +0.01 (+0.69%)
As of 08/25/2026 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Lisata Therapeutics (NASDAQ:LSTA)

Current
Institutional Ownership
Percentage
8.94%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$7.60M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$354.95K
Get LSTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lisata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LSTA Institutional Buying and Selling by Quarter

Lisata Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2026 Bank of America Corp DE10,353$35K0.0%N/A0.115%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.132,298$157K0.0%N/A1.468%
8/7/2026 BlackRock Inc.54,857$187K0.0%N/A0.602%
8/7/2026 BlackRock Inc.1,453,561$1.73M0.0%N/A15.963%
8/6/2026 GSA Capital Partners LLP269,410$321K0.0%N/A2.957%
5/15/2026 Rangeley Capital LLC75,000$376K0.3%N/A0.823%
5/14/2026 Renaissance Technologies LLC131,715$660K0.0%+6.5%1.446%
4/25/2026 SOL Capital Management CO12,175$61K0.0%N/A0.135%
4/24/2026 Deltec Asset Management LLC90,000$451K0.1%N/A0.997%
2/12/2026 Renaissance Technologies LLC123,715$230K0.0%+6.1%1.403%
2/12/2026 Dimensional Fund Advisors LP14,253$27K0.0%-32.0%0.162%
2/4/2026 Ground Swell Capital LLC38,987$73K0.2%+64.0%0.442%
2/3/2026 BML Capital Management LLC73,348$136K0.1%-33.2%0.832%
11/21/2025 CIBC Bancorp USA Inc.13,982$37K0.0%N/A0.159%
11/12/2025 Dimensional Fund Advisors LP20,947$55K0.0%-18.8%0.239%
11/10/2025 BML Capital Management LLC109,841$288K0.2%-47.6%1.254%
11/6/2025 Ground Swell Capital LLC23,774$62K0.1%N/A0.272%
8/14/2025 Cerity Partners LLC12,183$32K0.0%N/A0.139%
8/11/2025 BML Capital Management LLC209,814$608K0.5%-3.2%2.395%
5/7/2025BML Capital Management LLC216,853$510K0.4%-23.8%2.517%
2/17/2025Citadel Advisors LLC23,273$69K0.0%N/A0.277%
2/14/2025Dimensional Fund Advisors LP25,226$75K0.0%+45.5%0.301%
8/9/2024Dimensional Fund Advisors LP17,336$60K0.0%+48.2%0.209%
4/23/2024BML Capital Management LLC284,669$888K0.6%+5.5%3.426%
1/30/2024BML Capital Management LLC269,839$737K0.6%+10.7%3.315%
2/13/2023BML Capital Management LLC243,839$617K0.6%N/A3.102%


LSTA Institutional Ownership - Frequently Asked Questions

During the previous two years, 14 institutional investors and hedge funds held shares of Lisata Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($1.73M), Renaissance Technologies LLC ($660K), Deltec Asset Management LLC ($451K), Rangeley Capital LLC ($376K), GSA Capital Partners LLP ($321K), Connor Clark & Lunn Investment Management Ltd. ($157K), and BML Capital Management LLC ($136K).Learn more on Lisata Therapeutics' institutional investors.

8.94% of Lisata Therapeutics' stock is owned by institutional investors. Learn more on LSTA's institutional investor holdings.

Of the 13 institutional investors that purchased Lisata Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($1.51M), GSA Capital Partners LLP ($269.41K), Connor Clark & Lunn Investment Management Ltd. ($132.30K), Deltec Asset Management LLC ($90K), Rangeley Capital LLC ($75K), Ground Swell Capital LLC ($38.99K), and Citadel Advisors LLC ($23.27K).

Institutional investors have bought a total of 2,165,716 shares in the last 24 months. This purchase volume represents approximately $7.60M in transactions.

The following institutional investors have sold Lisata Therapeutics stock in the last 24 months: BML Capital Management LLC ($136.47K), and Dimensional Fund Advisors LP ($11.54K).

Institutional investors have sold a total of 148,006 shares in the last 24 months. This volume of shares sold represents approximately $354.95K in transactions.



Institutional ownership data for NASDAQ:LSTA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/17/2026. New 13F filings are added each quarter as they're published.
From Our Partners